St. Louis Suboxone Doctors

Dr. M.F. Ghani

M.F. Ghani, M.D.
6651 Chippewa Street, Suite #203
St. Louis, MO 63109

Phone: (314) 644-5300

Don’t let your dependence on opioids/pain killers control your life. We offer a compassionate, intensive and confidential Suboxone treatment to help you regain control and happiness in your life. Please call (314) 644-5300 to make an appointment today because you deserve special care.

Please call (314) 644-5300 to make an appointment

M.F. Ghani, M.D. – St. Louis, MO 63109

 

Join Here To Have Your Medical Practice Featured in this space

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

St. Louis offers a useful list of doctors approved to prescribe suboxone to patients coping with opioid withdrawal. Addiction to opioids results in a range of uncomfortable withdrawal symptoms (body ache, diarrhea, nausea, vomiting, insomnia, and more) which yield severe physical and mental stress and can lead to mood disorder and decreased ability to meet one’s daily responsibilities. Buprenorphine is the element in Suboxone that eliminates opioid withdrawal. Suboxone has arrived as a popular and effective opioid replacement medication that returns an individual’s functioning after a period of decline in active opioid addiction. Only approved physicians are legally able to write prescriptions for buprenorphine/suboxone. If you are a local physician aiming to treat St. Louis area residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



St. Louis Buprenorphine Suboxone Doctors
M. F. Ghani, M.D. 6651 Chippewa St., Suite 203
St. Louis, MO 63109
(314) 644-5300
Midwest Health Center – St. Louis
Dr. David Greengart MD
8630 Delmar Blvd,
Suite #230
St. Louis MO, 63124
(314) 472-5016
John Deno Rogakos, M.D. 665 South Skinker Boulevard
Suite 110
St. Louis, MO 63108
(314) 725-2199
Latanya C. Tunstall-Robinson, M.D. 625 North Euclid
Suite 214
St. Louis, MO 63108
(314) 361-0477
Gurpreet S. Padda, M.D. 5203 Chippewa
Suite 301
St. Louis, MO 63109
(314) 481-5000
Celso Rodrigues, M.D. Arca
6651 Chipewa, Suite 224
St. Louis, MO 63109
(314) 645-6840
Donald David Bohnenkamp, M.D. 660 South Euclid Avenue
Campus Box 8134
St. Louis, MO 63110
(314) 286-1700
Dragan Svrakic, M.D. 660 South Euclid Avenue
Campus Box 8134
St. Louis, MO 63110
(314) 362-3903
Celeste Herleth, M.D. 1129 Macklind Avenue
St. Louis, MO 63110
(314) 534-0200
Brent R. Palmer, M.D. Bridgeway Behavioral Health
1027 South Vandeventer
St. Louis, MO 63110
(636) 224-1700
Richard John Leahy, D.O. 5624-A South Compton Street
St. Louis, MO 63111
(412) 434-6700
David Michael Glick Family Care Health Centers
401 Holly Hills
St. Louis, MO 63111
(314) 353-5190
Jack Eldon Simons, D.O. 9733 St. Charles Rock Road
St. Louis, MO 63114
(314) 423-7030
Junaid M. Syed, M.D. 3535 South Jefferson
Suite 104
St. Louis, MO 63118
(314) 776-7990
Jordan M. Balter, D.O. 6220 S. Lindbergh Blvd
Suite 203
St. Louis, MO 63123
(314) 845-0571
John Stanley Rabun, M.D. 9890 Clayton Road
Suite 100
St. Louis, MO 63124
(314) 725-1515
Ahmad B. Ardekani, M.D. 10004 Kennerly Road
Suite 310A
St. Louis, MO 63128
(314) 843-3310
Ashok Yanamadala, M.D 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Azfar Malik, M.D. 5000 Cedar Plaza
Suite 350
St. Louis, MO 63128
(314) 843-4333×2
Narendir T. Soorya, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333×2
Gautam Datta, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Shazia Malik, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Mohinder Partap, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Vivek Agnihotri, M.D. 745 Old Frontenac Square
Suite 201
St. Louis, MO 63131
(314) 395-8940
Vadim Y. Baram, M.D. 10199 Woodfield Lane
St. Louis, MO 63132
(314) 504-4698
Christine Joan Salter, M.D. 777 South New Ballas Road
Suite 230W
St. Louis, MO 63141
(314) 395-9777
Edwin D. Dunteman, M.D. 555 North New Ballas
Suite 165
St. Louis, MO 63141
(314) 692-7246
Fazle M. Yasin, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 843-4333×2
Stephen C. Stromsdorfer, M.D. 1066 Executive Parkway
Suite 110
St. Louis, MO 63141
(314) 205-1707
Gautam Datta, M.D. Psych Care Consultants
763 South New Ballas Road, Suite 110
St. Louis, MO 63141
(314) 569-1717
Jo-Ellyn M. Ryall, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 569-1717
Azfar Malik, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 843-4333×2


Ohio Town Hall on Opioid Addiction

Several organizations in Ohio recently hosted a town hall discussion on the opioid crisis still occurring there and across the country. News commentator, Eric Bolling, was a moderator of the event which was held at Cedarville University.

Eric and his wife, Adrienne, lost their 19 year old son in 2017 due to an accidental overdose with the powerful opioid, fentanyl.

This town hall discussion was designed to continue raising public awareness on the danger of opioid misuse and the continuing need for treatment and recovery support services to help families deal with this perpetual problem.

The Centers for Disease Control (CDC) report that there were 70,237 drug overdoses in 2017 with 47,600 involving opioids specifically. The article linked above states that the state of Ohio ranked 2nd in overdose deaths only behind West Virginia.

There is promising news in that more Americans are now being educated on opioid risks, and consequently are taking better precautions as well as actively accessing methadone & suboxone programs offering helpful medication-assistance and behavioral counseling. Saving lives and offering recovery are messages that are being heard.

Posted in Buprenorphine, Fentanyl, Heroin Overdose, Methadone, Methadone Clinics, Opioid Addiction, Recovery, Suboxone | Tagged , | Comments Off on Ohio Town Hall on Opioid Addiction

Youth and Opioid Addiction

In past decades, opioid addiction was skewed more heavily toward an older generation of adults. But today we have larger numbers of youth using opioids and experiencing addiction-related problems at earlier ages. Importantly, research has demonstrated conclusively that those who remain engaged in treatment for six months or more are much more likely to stabilize and to enjoy sustained success with recovery.

A recent Reuters Health article highlights the fact that many opioid-addicted youth are either not yet engaging in treatment or are exiting treatment too early. While more youth are being saved through the overdose reversal drug naloxone, a majority of addicted youth are still not receiving medicated-assisted treatments such as buprenorphine or methadone.

More work is necessary to open up treatment avenues for young adults across America, and to both educate & compel youth to seek MAT (medication-assisted treatment) as soon as possible.

The opioid addiction problem in America will not soon disappear. Drugs continue to find their way across the U.S. border through multiple avenues. Positive efforts are indeed bringing needed change, but the complexity and extent of opioid addiction in the U.S. will require a long-term, sustained commitment throughout the country. We must get the message out – especially to young people who may not fully grasp the power of addiction!

Posted in Addiction Treatment, Buprenorphine, Heroin, Methadone Clinics, Opiate Addiction, Opioid Addiction, Recovery, Rehab For Teens, Suboxone | Tagged , , | Comments Off on Youth and Opioid Addiction

Opioid Use Disorder A Modern Reality

Opioid Use Disorder is the newer clinical terminology (from the DSM5) used to describe the full range of opioid problems ranging from mild opioid-related use issues to severe opioid addiction.

The CDC reports that in 2017 there were 72,287 deaths from overdose in the United States. That is certainly an alarming statistic. Of that number, 49,060 of those deaths were from opioids specifically – just in 2017. By contrast, there were 58,200 U.S. fatalities that resulted from the entire Vietnam war.

The good news is that government funding for opioid treatment is finally entering the stream on a local level. Increasing numbers of methadone clinics and physicians authorized to prescribe buprenorphine are moving into America’s more rural areas, ones that have historically been severely underserved.

As treatment for Opioid Use Disorder becomes more readily available, people struggling under the constant pressure of addiction will have an opportunity to apply the brake, and to veer onto a new path of stability and recovery. That being said, it is estimated that presently only 1 person of 10 with an opioid use disorder has sought treatment. For many opioid addicted people, treatment made the difference between life and death.

Choose a new path is more than words for those that have truly done so. Addiction is a highly persistent disease, but change is possible. Commitment and action are the necessary ingredients in opening the door to a new life. Opioid Use Disorder, in particular, is successfully treated with medication assistance. Science, research, and life experience have fortunately reinforced this fact with perfect clarity. Please find a local treatment provider today!

Posted in Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Methadone Maintenance, Suboxone, Suboxone Doctors, Suboxone Physicians | Tagged , , | Comments Off on Opioid Use Disorder A Modern Reality

ADAPT Pharma Provides Free Narcan to Colleges

A Presidential briefing on March 19, 2018 in Manchester, NH was used to announce that ADAPT Pharma has volunteered to provide, for free, the life-saving medication NARCAN® to all U.S. high schools, colleges and universities.

NARCAN® is a name brand overdose antidote (based on naloxone) that restores breathing and consciousness in opioid overdose victims typically within five minutes.

ADAPT Pharma offers a 40% discount off wholesale pricing on the Narcan nasal spray to Law Enforcement agencies and Firefighters as well as non-profit community based organizations.

Seamus Mulligan, CEO of ADAPT, commented in a company press release that ADAPT is committed to raising awareness of opioid overdose risks and distributing NARCAN® widely so that it will be available to bystanders and emergency personnel who can offer immediate help in the event of a crisis.

Posted in Addiction Treatment, Methadone, Naloxone, Opiate Treatment, Suboxone | Tagged , , | Comments Off on ADAPT Pharma Provides Free Narcan to Colleges